NeuroOne Medical Technologies
NMTC

$0.9350

8.85%

Market Cap: $28.8M

About: NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Employees: 16

Healthcare Surgical & Medical Instruments & Apparatus

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

2.26% more ownership

Funds ownership: 10.98% [Q1] → 13.24% (+2.26%) [Q2]

0% more funds holding

Funds holding: 18 [Q1] → 18 (+0) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

14% less capital invested

Capital invested by funds: $3.42M [Q1] → $2.95M (-$468K) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for NMTC.

See Analyst Rankings

Financial journalist opinion

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

Forty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that the OneRF Ablation System was recently used in a breakthrough patient procedure at the University Hospitals in Cleveland to successfully complete forty four ablations in one patient.

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

EDEN PRAIRIE, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its upcoming virtual investor presentation at the H.C. Wainwright 26th Annual Global Investment Conference being held in-person and virtually on September 9-11, 2024.

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Welcome to the NeuroOne Medical Technologies Corporation Third Quarter of Fiscal Year 2024 Financial Results Conference Call.

NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Aug. 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the third quarter fiscal year 2024 ended June 30, 2024.

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

EDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on August 14, 2024, at 4:30 PM Eastern Time to discuss financial results for its third quarter of fiscal year 2024 ended June 30, 2024, and provide a corporate update.

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

The 3 Best Neuroscience Biotech Stocks to Buy Now

Problems with the central nervous system are the second leading cause of death globally, the World Health Organization determined in 2022. One reason for this situation is that it's extremely difficult to develop effective treatments for these disorders because of the complexity of the CNS, European biotech news website Labiotech reported last year.

The 3 Best Neuroscience Biotech Stocks to Buy Now

3 Neurotech Stocks Bridging Mind and Machine

If the prospect of controlling computers and robots with brainpower alone excites you, neurotech stocks are right up your alley. Unfortunately, today's top neurotech company — Elon Musk's Neuralink — remains off-limits to retail investors.

3 Neurotech Stocks Bridging Mind and Machine

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Dave Rosa - President & Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Welcome to the NeuroOne Medical Technologies Corporation Second Quarter of Fiscal Year 2024 Financial Results Conference Call.

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter fiscal year 2024 ended March 31, 2024.

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

See News Rankings